Liliana B. Munoz-Endo

Heidelberg, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.

Journal: Journal for immunotherapy of cancer

Published: March 03, 2020

Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma.

Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma.

Journal: Veterinary and comparative oncology

Published: January 23, 2019

Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.

Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.

Journal: Oncotarget

Published: November 16, 2015

Auranofin is a potent suppressor of osteosarcoma metastasis.

Auranofin is a potent suppressor of osteosarcoma metastasis.

Journal: Oncotarget

Published: September 10, 2015

Dysregulation of epidermal growth factor receptor in actinic keratosis and squamous cell carcinoma.

Dysregulation of epidermal growth factor receptor in actinic keratosis and squamous cell carcinoma.

Journal: Current problems in dermatology

Published: January 07, 2015

Confluence-Induced Squamous Differentiation Is Not Accompanied by Changes in H3K27me3 Repressive Epigenetic Mark.

Confluence-Induced Squamous Differentiation Is Not Accompanied by Changes in H3K27me3 Repressive Epigenetic Mark.

Journal: The Journal of investigative dermatology

Published: December 03, 2014

A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma.

A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 21, 2014

Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.

Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.

Journal: PloS one

Published: August 05, 2014

Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.

Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 29, 2012

Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.

Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.

Journal: Molecular cancer

Published: May 21, 2012

Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.

Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.

Journal: EMBO molecular medicine

Published: December 05, 2011

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma.

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma.

Journal: British journal of cancer

Published: November 26, 2011

Showing 1-12 of 14

Last Updated: 09/26/2026